EC
DTIL icon

EcoR1 Capital’s Precision BioSciences DTIL Stock Holding History

EcoR1 Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-167,866
Closed -$5.99M – 62
2022
Q4 		$5.99M Hold
167,866
– – 0.18% 47
2022
Q3 		$6.55M Hold
167,866
– – 0.19% 42
2022
Q2 		$8.06M Buy
+167,866
New +$9.85M 0.28% 42

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital's DTIL Position: Q1 2023 in Review

EcoR1 Capital sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 167,866 shares — an estimated $5.99M sold.

EcoR1 Capital first reported a position in DTIL in Q2 2022 and held it in 3 quarters. The position peaked at $8.06M in Q2 2022. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • EcoR1 Capital reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • EcoR1 Capital sold 167,866 Precision BioSciences shares in Q1 2023, an estimated $5.99M.
  • EcoR1 Capital first reported a position in Precision BioSciences in Q2 2022 and held it in 3 quarters.
  • EcoR1 Capital's Precision BioSciences position peaked at $8.06M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on EcoR1 Capital's 13F filing for Q1 2023, filed 15 May 2023.